Calcium, serum

Current nutritional intake Complete blood cell count Serum electrolytes Sodium Potassium Chloride Bicarbonate Magnesium Phosphorous Calcium Serum glucose Serum albumin Markers for organ function Liver function tests Alkaline phosphatase Aspartate aminotransferase Alanine aminotransferase Total bilirubin Prothrombin time or International normalized ratio Renal function tests Blood urea nitrogen Creatinine Fluid balance Input Oral... 

Adjusted serum calcium, serum alkaline phosphatase, osteocalcin, and urinary hy-droxyproline levels to assess the effectiveness of tiludronate... 

In 53 patients studied prospectively at 1, 6, 12, and 24 months, lithium increased serum PTH concentrations (apparent by 6 months) and increased renal reabsorption of calcium in the absence of a significant change in serum calcium (660). A prospective study of 101 lithium maintenance patients and 82 healthy controls showed higher serum calcium concentrations during lithium treatment than at baseline or in the controls, and higher calcium serum concentrations in those lithium patients over 60 years of age (633). 

Aspartate aminotransferase (AST, GOT at 30 C) Bilirubin, serum (adult) Total II Direct Calcium, serum (Ca +)... 

The disorders of calcium homeostasis are related to the calcium content of the extracellular fluid, which contains less than 0.5% of the total body stores of calcium. Skeletal bone contains more than 99% of total body stores of calcium. ECF calcium is moderately bound to plasma proteins (46%), primarily albumin. Unbound or ionized calcium is the physiologically active form and is the fraction that is homeostatically regulated. Extracellular calcium, however, is most commonly measured as the total serum calcium level, which includes both bound and unbound calcium. The normal total calcium serum concentration range is 8.5 to 10.5 mg/dL. °... 

Calcium, urine 0-300 mg/24 h, or 0.0-7.5 mmol/24 h. Ionized calcium (serum calcium not bound to protein) ranges in adults from 4.65 to 5.28 mg/ dL. The level of ionized calcium in the blood is not affected by the amount of protein in the blood. 

White phosphorus. This element burns in air and can produce severe thermal and chemical burns. It may reignite on drying. After washing, rapid but brief treatment with copper sulphate (to avoid systemic absorption and copper poisoning) is used to convert the phosphorus to copper phosphide which is then removed Hydrogen fluoride. This can form painful but delayed necrosis. Treat with calcium gluconate locally and monitoring of serum calcium levels, with administration of calcium where necessary... 

PTH is the most important regulator of bone remodelling and calcium homeostasis. PTH is an 84-amino acid polypeptide and is secreted by the parathyroid glands in response to reductions in blood levels of ionised calcium. The primary physiological effect of PTH is to increase serum calcium. To this aim, PTH acts on the kidney to decrease urine calcium, increase mine phosphate, and increase the conversion of 25-OH-vitamin D to l,25-(OH)2-vitamin D. PTH acts on bone acutely to increase bone resorption and thus release skeletal calcium into the circulation. However, due to the coupling of bone resorption and bone formation, the longer-term effect of increased PTH secretion is to increase both bone resorption and bone formation. 

The steroid hormone 1,25-dihydroxy vitamin D3 (calcitriol) slowly increases both intestinal calcium absorption and bone resorption, and is also stimulated through low calcium levels. In contrast, calcitonin rapidly inhibits osteoclast activity and thus decreases serum calcium levels. Calcitonin is secreted by the clear cells of the thyroid and inhibits osteoclast activity by increasing the intracellular cyclic AMP content via binding to a specific cell surface receptor, thus causing a contraction of the resorbing cell membrane. The biological relevance of calcitonin in human calcium homeostasis is not well established. 

PTH has a dual effect on bone cells, depending on the temporal mode of administration given intermittently, PTH stimulates osteoblast activity and leads to substantial increases in bone density. In contrast, when given (or secreted) continuously, PTH stimulates osteoclast-mediated bone resorption and suppresses osteoblast activity. Further to its direct effects on bone cells, PTH also enhances renal calcium re-absorption and phosphate clearance, as well as renal synthesis of 1,25-dihydroxy vitamin D. Both PTH and 1,25-dihydroxyvitamin D act synergistically on bone to increase serum calcium levels and are closely involved in the regulation of the calcium/phosphate balance. The anabolic effects of PTH on osteoblasts are probably both direct and indirect via growth factors such as IGF-1 and TGF 3. The multiple signal transduction... 

The parathyroid glands in FHH are reset to maintain a higher than normal serum calcium concentration owing to impaired suppression of PTH release in the face of hypercalcemia (e.g., resistance to CaQ+) (Fig. 2). Similarly the kidneys show a reduced calciuric response to hypercalcemia, which contributes to the hypercalcemia by promoting inappropriately reabsorption of calcium. Mouse models of FHH and NSHPT result from targeted inactivation of one or both CaR alleles, respectively [1,3]. These animals have provided valuable insights into the alterations in tissue function resulting from loss of the receptor. 

In bone, three proteins have been described which are vitamin K-dependent, osteocalcin (bone Gla protein), matrix Gla protein (MGP), and protein S. Osteocalcin is synthetized by osteoclasts, regulated by the active form of vitamin D, calcitriol. Its capacity to bind calcium needs a vitamin K-dependent y-carboxylation of three glutamic acid residues. The calcium binding capacity of osteocalcin indicates a possible role in bone mineralization, but its exact function is still unclear. However, it is widely used as a serum marker for bone mineralization. Protein S, mainly a coagulant, is also vitamin-K dependent and synthesized in the liver. Children with... 

When alendronate and risedronate are administered, serum calcium levels are monitored before, during, and after therapy. 

If die nitrates are administered witii the antihypertensives, alcohol, calcium channel blockers, or the phe-notiiiazines, there may be an increased hypotensive effect. When nitroglycerin is administered intravenously (IV), die effects of heparin may be decreased. Increased nitrate serum concentrations may occur when the nitrates are administered witii aspirin. 

When these drugs are given to the female patient with inoperable breast carcinoma, tire nurse evaluates the patient s current status (physical, emotional, and nutritional) carefully and records tire finding in tire patient s chart. Problem areas, such as pain, any limitation of motion, and the ability to participate in tire activities of daily living, are carefully evaluated and recorded in tiie patient s record. The nurse takes and records vital signs and weight. Baseline laboratory tests may include a complete blood count, hepatic function tests, serum electrolytes, and serum and urinary calcium levels. The nurse reviews these tests and notes any abnormalities. 

Mallinckrodt anhydrous diethyl ether was purified by refluxing with calcium hydride under nitrogen for at least 2 hours and distilling under nitrogen immediately before use. For use in the preparation of the propenyllithium, approximately 650 ml. of ether should be collected in a dry 1-1. graduated flask capped with a serum stopper. 

Decreased serum calcium has also been observed following a 7-week oral exposure to 5 mg/kg/day of endosulfan (Garg et al. 1980). 

---